CenterWatch

Cushing's Disease Clinical Trials

A listing of Cushing's Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Alabama

Birmingham Alabama 35294

A Phase 2 clinical study for patients with Cushing's Disease

Arizona

Peoria Arizona 85381

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Phoenix Arizona 85013

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

California

Los Angeles California 90095

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

San Diego California 92108

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Torrance California 90502

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Illinois

Chicago Illinois 60612

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Maryland

Johns Hopkins University School of Medicine Division of Endocrinology, Diabetes & Metabolism
Baltimore Maryland 21287

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Michigan

University of Michigan Medical Center Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Ann Arbor Michigan 48109

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Ann Arbor Michigan 48109-0944

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

Nebraska

Omaha Nebraska 68131

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

New Mexico

University of New Mexico HSC
Albuquerque New Mexico 87131

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

New York

Icahn School of Medicine at Mount Sinai
New York New York 10029

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

New York New York 10029

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

New York New York 10032

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

Ohio

Cleveland Clinic Endocrinology
Cleveland Ohio 44195

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

CarePoint East
Columbus Ohio 43203

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Oregon

Oregon Health & Science University
Portland Oregon

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Portland Oregon 97239

A Phase 2 clinical study for patients with Cushing's Disease

Portland Oregon 97239

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Pennsylvania

University of Pennslyvania Smilow Center for Translational Research
Philadelphia Pennsylvania 19104-5160

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Pittsburgh Pennsylvania 15212

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Tennessee

Nashville Tennessee 37203

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Wisconsin

Milwaukee Wisconsin 53226

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

Belgium

UZLeuven Dienst endocrinologie
Leuven International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

France

Endocrinologie, Pavillon des Ecrins Centre Hospitalier Universitaire, Hopital Nord
Cedex International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Hôpital de la TIMONE Department of Endocrinology and Reference Center for Rare Pituitary Diseases
Marseille International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Centre de Réference Maladies Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Paris International 75014

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Israel

Institute of Endocrinology & Metabolism Rabin Medical Center, Beilinson Campus
Petah Tiqva International 49100

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Netherlands

Erasmus MC, Dpt. Of Internal Medicine, Division of Endocrinology Centre Hospitalier Universitaire, Hopital Nord
Rotterdam International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Spain

Hospital Universitario de la Ribera Centre Hospitalier Universitaire, Hopital Nord
Alzira-Valencia International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Hospital Sant Pau, Universitat Autònoma de Barcelona
Barcelona International 08025

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Argentina

Caba Buenos Aires C1280AEB

A Phase 2 clinical study for patients with Cushing's Disease

Caba Buenos Aires C1426AAI

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

Australia

Adelaide South Australia 5000

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

Darlinghurst New South Wales 2010

A Phase 2 clinical study for patients with Cushing's Disease

Woolloongabba Queensland 4102

A Phase 2 clinical study for patients with Cushing's Disease

Austria

Linz A-4020

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

Wien 1090

Patients are needed to participate in a clinical research study evaluating LCI699 for the treatment of Cushing's Disease

Belgium

Ghent 9000

A Phase 2 clinical study for patients with Cushing's Disease

Leuven 3000

A Phase 2 clinical study for patients with Cushing's Disease

Brazil

Fortaleza CE 04636-000

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Joinville SC 89201260

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Londrina PR

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

Porto Alegre RS 90560-030

A Phase 2 clinical study for patients with Cushing's Disease

Porto Alegre RS 90560-030

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease

View More ▼

Rio de Janeiro RJ 21941-913

Patients are needed to participate in a clinical research study of Pasireotide sub-cutaneous formulation to evaluate Cushing's Disease